• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺混合性化生癌:一例报告

Mixed metaplastic carcinoma of the breast: a case report.

作者信息

Tower Amelia, Hughes Jonathan, Moore Lauren, Srivastava Kumaraman

机构信息

Texas Health Breast Specialists, Texas Health Harris Methodist Hospital, Fort Worth, TX 76104, USA.

Texas Health Harris Methodist Hospital, Fort Worth, TX 76104, USA.

出版信息

J Surg Case Rep. 2023 Mar 14;2023(3):rjad144. doi: 10.1093/jscr/rjad144. eCollection 2023 Mar.

DOI:10.1093/jscr/rjad144
PMID:36926632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10014167/
Abstract

A 68 year-old woman with no significant medical history discovered a lump incidentally in her left breast. The patient's initial imaging revealed a 4.6-cm irregular mass at 11:00 categorized as a BI-RADS 5 as well as an enlarged axillary lymph node and an area of 2.5 cm of heterogeneous calcifications in the 3 o'clock position. The 4.6-cm lesion was revealed to be infiltrating ductal carcinoma with a squamous component, mixed metaplastic carcinoma, which was strongly ER (100+)/PR (100+) positive, HER-2/Neu negative on FISH. The 2.5-cm calcifications were ductal carcinoma . The patient completed neoadjuvant chemotherapy, and had an excellent response. After further discussion, the patient elected for breast conservation therapy and underwent a left wireless localized partial mastectomy with a left axillary dissection. Surgical pathology revealed a near complete pathologic response with only 8-mm residual tumour as well as a negative conversion of the clipped axillary node.

摘要

一名68岁无重大病史的女性偶然发现左乳有一个肿块。患者最初的影像学检查显示,在11点位置有一个4.6厘米的不规则肿块,分类为BI-RADS 5级,还有一个腋窝淋巴结肿大,以及在3点位置有一个2.5厘米的异质性钙化区域。4.6厘米的病变被诊断为浸润性导管癌伴鳞状成分,即混合性化生癌,雌激素受体(ER,100+)/孕激素受体(PR,100+)强阳性,荧光原位杂交(FISH)检测HER-2/Neu阴性。2.5厘米的钙化灶为导管癌。患者完成了新辅助化疗,反应良好。经过进一步讨论,患者选择了保乳治疗,接受了左乳无导线局部部分乳房切除术及左腋窝淋巴结清扫术。手术病理显示几乎完全病理缓解,仅残留8毫米肿瘤,且夹取的腋窝淋巴结转为阴性。

相似文献

1
Mixed metaplastic carcinoma of the breast: a case report.乳腺混合性化生癌:一例报告
J Surg Case Rep. 2023 Mar 14;2023(3):rjad144. doi: 10.1093/jscr/rjad144. eCollection 2023 Mar.
2
Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.HER2阳性转移性乳腺癌女性的当前及新出现的治疗方法
J Adv Pract Oncol. 2017 Mar;8(2):164-168. Epub 2017 Mar 1.
3
Metaplastic breast cancer with chondroid differentiation.伴有软骨样分化的化生性乳腺癌。
J Community Hosp Intern Med Perspect. 2015 Sep 1;5(4):28935. doi: 10.3402/jchimp.v5.28935. eCollection 2015.
4
Treatment of Pregnancy-Associated Breast Cancer.妊娠相关乳腺癌的治疗
J Adv Pract Oncol. 2019 Sep-Oct;10(7):692-700. doi: 10.6004/jadpro.2019.10.7.5. Epub 2019 Sep 1.
5
A rare case of breast squamous cell carcinoma and literature review.1例罕见的乳腺鳞状细胞癌病例及文献复习
Ann Med Surg (Lond). 2022 May 18;78:103825. doi: 10.1016/j.amsu.2022.103825. eCollection 2022 Jun.
6
Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.以隐匿性乳腺癌伴腋窝及锁骨上淋巴结转移表现的乳腺腺癌:1例报告
Cureus. 2023 May 27;15(5):e39583. doi: 10.7759/cureus.39583. eCollection 2023 May.
7
The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.新辅助化疗病理完全缓解后局部晚期乳腺癌保乳术后放疗的作用。
Oncology (Williston Park). 2021 Mar 15;35(3):139-143. doi: 10.46883/ONC.2021.3503.0139.
8
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.在早期乳腺癌的辅助治疗中,在紫杉烷的基础上加用蒽环类药物以最大化临床获益。
J Clin Oncol. 2017 Aug 10;35(23):2600-2603. doi: 10.1200/JCO.2017.72.5960. Epub 2017 Jun 29.
9
Metaplastic breast cancer with a unique presentation and complete response to chemotherapy: a case report.具有独特表现和完全化疗反应的化生性乳腺癌:病例报告。
BMC Womens Health. 2024 May 11;24(1):285. doi: 10.1186/s12905-024-03134-8.
10
Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature.新辅助化疗联合曲妥珠单抗治疗后HER-2 Neu阳性浸润性导管癌及导管原位癌的病理完全缓解:1例报告并文献复习
Case Rep Surg. 2012;2012:454273. doi: 10.1155/2012/454273. Epub 2012 Jan 19.

本文引用的文献

1
Clinicopathologic Features of Metaplastic Breast Carcinoma: Experience From a Tertiary Cancer Center of North India.化生性乳腺癌的临床病理特征:来自印度北部一家三级癌症中心的经验
Cureus. 2022 Sep 9;14(9):e28978. doi: 10.7759/cureus.28978. eCollection 2022 Sep.
2
Metaplastic Breast Cancer: Characteristics and Survival Outcomes.化生性乳腺癌:特征与生存结局
Cureus. 2022 Aug 29;14(8):e28551. doi: 10.7759/cureus.28551. eCollection 2022 Aug.
3
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma.化生性乳腺癌对新辅助化疗反应不佳。
NPJ Breast Cancer. 2021 Jul 22;7(1):96. doi: 10.1038/s41523-021-00302-z.
4
The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database.辅助化疗在化生性乳腺癌中的作用:基于监测、流行病学和最终结果(SEER)数据库的竞争风险分析
Front Oncol. 2021 Apr 26;11:572230. doi: 10.3389/fonc.2021.572230. eCollection 2021.
5
Metaplastic Breast Carcinoma: Experience of a Tertiary Cancer Center in the Middle East.化生性乳腺癌:中东一家三级癌症中心的经验
Cancer Control. 2021 Jan-Dec;28:10732748211004889. doi: 10.1177/10732748211004889.
6
A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations.化生性乳腺癌的全面概述:临床特征和分子异常。
Breast Cancer Res. 2020 Nov 4;22(1):121. doi: 10.1186/s13058-020-01353-z.
7
Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes.化生性乳腺癌与其他乳腺癌亚型的治疗后结局
J Cancer. 2020 Jan 1;11(6):1341-1350. doi: 10.7150/jca.40817. eCollection 2020.
8
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy.化生性乳腺癌对新辅助全身治疗反应差。
Breast Cancer Res Treat. 2019 Aug;176(3):709-716. doi: 10.1007/s10549-019-05264-2. Epub 2019 May 22.
9
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy.化生性乳腺癌:97 例临床病理研究及新辅助化疗反应的亚组分析。
Mod Pathol. 2019 Jun;32(6):807-816. doi: 10.1038/s41379-019-0208-x. Epub 2019 Feb 5.
10
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma.45例化生性乳腺癌患者的临床病理分析
Am J Clin Pathol. 2016 Mar;145(3):365-72. doi: 10.1093/ajcp/aqv097. Epub 2016 Feb 19.